Close
Help
Need Help?



Clinical Medicine Insights: Women's Health Joins COPE

Posted Thu, Sep, 13,2012

Clinical Medicine Insights: Women's Health has formally joined the Committee on Publishing Ethics.COPE provides guidelines that are applied in situations such as where plagiarism allegations are made against a paper.  By becoming a COPE member there can be no doubt amongst authors of questionable papers that journals will apply commonly accepted industry-standard guidelines.  In more...

Continue Reading →

Posted in: Libertas Services

Biomarker Insights Indexing Partners

Posted Thu, Sep, 13,2012

Libertas works continually to increase online visibility for all our journals, and we are pleased to report that Biomarker Insights is now indexed by 22 external online databases and in 11 online directories and search engines.Indexing with so many external databases and directories means that articles published in Biomarker Insights are searchable in many places, meaning they are more visible to ...

Continue Reading →

Most read paper in Bone and Tissue Regeneration Insights

Posted Thu, Sep, 13,2012

Bone and Tissue Regeneration Insights is an open access journal, meaning all articles are available for anyone to download freely without restriction. Open access journals are renowned for having high levels of article visibility compared to traditional subscription journals.One good example of how open access journals can offer high visibility is 'Tissue Engineering Options for Ligament Heali...

Continue Reading →

Open Access Visibility Statistics for International Journal of Insect Science

Posted Thu, Sep, 13,2012

Articles published in open access journals like International Journal of Insect Science are likely to receive more citations and a higher level of visibility than articles published in restricted access journals.Libertas’ goal is to maximize visibility for all articles published in International Journal of Insect Science and articles in the journal have been viewed more than 30,775 times sin...

Continue Reading →

New Immunotherapy Insights Call for Papers

Posted Thu, Sep, 13,2012

The Editor in Chief, Dr John Barrett, is pleased to announce a new call for papers for Immunotherapy Insights. Submissions are being accepted now.All authors who submit their manuscripts to Libertas will benefit from:Professional Manuscript EditingConvenient 3-step online manuscript submissionNo space restrictions or color figure chargesOptional immediate publicationInclusion of your article in: C...

Continue Reading →

Posted in: Calls for Papers

Forthcoming Articles 10 - 14 September 2012

Posted Thu, Sep, 13,2012

Libertas is pleased to announce that during the week of 10 - 14 September 2012 production commenced for the following articles:Breast Cancer: Basic and Clinical ResearchSafety and efficacy of nanoparticle albumin-bound paclitaxel for the treatment of metastatic breast cancerClinical Medicine Insights: Case ReportsJuvenile Xanthogranuloma presenting as bilateral non-infiltrative extraconal superior...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
I serve as a peer reviewer for Libertas Academica and I would say LA is a great publisher to work with.  The online review system is easy to navigate and the review process is straightforward.  I am really looking forward to reviewing more manuscripts and submitting my own results as well in the future.
Dr Jianxiong Jiang (Department of Pharmacology, Emory University School of Medicine, Atlanta, GA, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results